Your browser doesn't support javascript.
loading
Loss of voltage-gated hydrogen channel 1 expression reveals heterogeneous metabolic adaptation to intracellular acidification by T cells.
Coe, David; Poobalasingam, Thanushiyan; Fu, Hongmei; Bonacina, Fabrizia; Wang, Guosu; Morales, Valle; Moregola, Annalisa; Mitro, Nico; Cheung, Kenneth Cp; Ward, Eleanor J; Nadkarni, Suchita; Aksentijevic, Dunja; Bianchi, Katiuscia; Norata, Giuseppe Danilo; Capasso, Melania; Marelli-Berg, Federica M.
Afiliação
  • Coe D; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Poobalasingam T; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Fu H; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Bonacina F; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Wang G; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Morales V; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Moregola A; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Mitro N; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Cheung KC; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Ward EJ; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Nadkarni S; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Aksentijevic D; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Bianchi K; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Norata GD; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
  • Capasso M; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Research Institute, Queen Mary University of London, London, United Kingdom.
  • Marelli-Berg FM; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, United Kingdom.
JCI Insight ; 7(10)2022 05 23.
Article em En | MEDLINE | ID: mdl-35472029
ABSTRACT
Voltage-gated hydrogen channel 1 (Hvcn1) is a voltage-gated proton channel, which reduces cytosol acidification and facilitates the production of ROS. The increased expression of this channel in some cancers has led to proposing Hvcn1 antagonists as potential therapeutics. While its role in most leukocytes has been studied in depth, the function of Hvcn1 in T cells remains poorly defined. We show that Hvcn1 plays a nonredundant role in protecting naive T cells from intracellular acidification during priming. Despite sharing overall functional impairment in vivo and in vitro, Hvcn1-deficient CD4+ and CD8+ T cells display profound differences during the transition from naive to primed T cells, including in the preservation of T cell receptor (TCR) signaling, cellular division, and death. These selective features result, at least in part, from a substantially different metabolic response to intracellular acidification associated with priming. While Hvcn1-deficient naive CD4+ T cells reprogram to rescue the glycolytic pathway, naive CD8+ T cells, which express high levels of this channel in the mitochondria, respond by metabolically compensating mitochondrial dysfunction, at least in part via AMPK activation. These observations imply heterogeneity between adaptation of naive CD4+ and CD8+ T cells to intracellular acidification during activation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prótons / Hidrogênio Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prótons / Hidrogênio Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article